Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study

NCT01077401 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT01077401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01077401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2010
Completion date
March 31, 2013
Enrollment
152 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema